Skip to main content
. 2015 Oct 5;2015:971616. doi: 10.1155/2015/971616

Figure 4.

Figure 4

The incidence of YMDD mutation: comparison of lamivudine plus OMTR therapies and lamivudine therapy. RR, relative risk; CI, confidence interval; test for heterogeneity: Chi-squared statistic with its degrees of freedom (df) and p value; inconsistency among results: I 2 test for overall effect; Z statistic with p value.